GSR and Charlie Lee Lead $100M Investment into MEI, Reveal Institutional LTC Treasury Strategy
GSR, a crypto market maker and trading firm, has announced an investment in and a strategic partnership with the Nasdaq-listed MEI Pharma, marking the first time a public company is aligning its treasury strategy with Litecoin (LTC) at an institutional level, the team says. According to the press release, GSR and Litecoin founder Charlie Lee…